Unknown

Dataset Information

0

Total synthesis of remdesivir.


ABSTRACT: Remdesivir, the first drug approved by the FDA to treat COVID-19, is in high demand for patients infected with the SARS-CoV-2 virus. Herein, we report a facile approach minimizing the protecting group manipulations to afford remdesivir in good overall yield.

SUBMITTER: Kumar Palli K 

PROVIDER: S-EPMC8656175 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Remdesivir, the first drug approved by the FDA to treat COVID-19, is in high demand for patients infected with the SARS-CoV-2 virus. Herein, we report a facile approach minimizing the protecting group manipulations to afford remdesivir in good overall yield. ...[more]

Similar Datasets

| S-EPMC9366944 | biostudies-literature
| S-EPMC2752835 | biostudies-literature
| S-EPMC3578506 | biostudies-literature
| S-EPMC8159391 | biostudies-literature
| S-EPMC8025790 | biostudies-literature
| S-EPMC3148190 | biostudies-literature
| S-EPMC4941107 | biostudies-literature
| S-EPMC1480405 | biostudies-literature
| S-EPMC10690800 | biostudies-literature
| S-EPMC5484051 | biostudies-literature